Oxbridge Re prices $3m registered direct offering and private placement

Oxbridge Re, together with its subsidiaries, has announced a $3.0 million registered direct offering and concurrent private placement.

The company has entered into a securities purchase agreement with a single institutional investor for the purchase of 705,884 ordinary shares in a registered direct offering.

Concurrently, Oxbridge Re will issue unregistered Series A Warrants to purchase up to 529,413 ordinary shares and unregistered Series B Warrants to purchase up to 882,355 ordinary shares in a private placement.

The combined effective offering price for each ordinary share and the accompanying warrants is $4.25.

According to the announcement, the Series A Warrants will be immediately exercisable with a two-year expiration and $4.25 exercise price, while Series B Warrants will be exercisable after shareholder approval or 6 months from issuance with a five-year expiration.

The offering is expected to close around February 26, 2025, with Maxim Group acting as the sole placement agent.

Oxbridge Re concluded: “The Series A Warrants and Series B Warrants to be issued in the concurrent private placement and the ordinary shares issuable upon exercise of such warrants were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Act”), and Regulation D promulgated thereunder and have not been registered under the Act or applicable state securities laws.”

This capital raise comes as Oxbridge transitions from its traditional reinsurance business toward tokenized Real-World Assets (RWAs) – initially in the form of tokenized reinsurance securities, and reinsurance solutions to property and casualty insurers in the Gulf Coast region of the United State.

This website states: The content on this site is sourced from the internet. If there is any infringement, please contact us and we will handle it promptly.